A case of pulmonary mucormycosis with limited clinical signs and symptoms in a controlled diabetic patient

Koomesh

Volumn 10, Issue 1, 2008, Pages

  Malek, Farhad ^a   Malek, Mojtaba ^a   Toosi, Jafar ^a   Tamadon, Mohammad Reza ^a   Zahmatkesh, Mehrdad ^a  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Pulmonary mucormycosis; Well controlled

Indexed keywords

AMPHOTERICIN B;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC PATIENT; DRUG TREATMENT FAILURE; HUMAN; LUNG MYCOSIS; MUCORMYCOSIS;

EID: 77449131660     PISSN: 16087046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ning L, Carter D. Pulmonary Mucormycosis: Report of two cases and review of the literature. Pathol Case Rev 2003; 8: 275.
2. Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, and Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994; 57: 1044-1050
3. Joshi N, Caputo GM, Weitekamp MR, and Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-1912.
4. Bhansali A, Sharma A, Kashyap A, Gupta A, and Dash RJ. Mucor endophthalmitis. Acta Ophthalmol Scand 2001; 79: 88-90.
5. Tsaousis G, Koutsouri A, Gatsiou C, Paniara O, Peppas C, and Chalevelakis G. Liver and brain mucormycosis in a diabetic patient type II successfully treated with liposomal amphotericin B. Scand J Infect Dis 2000; 32: 335-337.
6. Wiedermann BL. Zygomycosis. In: book of Pediatric Infectious Diseases, 3rd edn. Eds. Feigin RD, Cherry JD , Philadelphia, W.B. Saunders, 1992, pp: 1968-1973.
7. Bigby TD, Serota ML, Tierney LM, and Matthay MA. Clinical spectrum of pulmonary mucormycosis. Chest 1986, 89: 435-439.
8. Kobayashi M, Togitani K, Machida H, Uemura Y, Ohtsuki Y, and Taguchi H. Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by Cunninghamella bertholletiae. Respirology 2004; 9: 397-401.
9. Murray HW. Pulmonary mucormycosis: one hundred years later. Chest 1977; 72: 1-2.
10. Bigby TD, Serota ML, Tierney LM Jr, and Matthay MA. Clinical Spectrum of Pulmonary Mucormycosis. Chest. 1986; 89: 435-439.
11. Lee FY, Mossad SB, and Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med 1999; 159: 1301-1309.
12. Glazer M, Nusair S, Breuer R, Lafair J, Sherman Y, and Berkman N. The role of BAL in the diagnosis of pulmonary mucormycosis. Chest 2000; 117: 279-282.
13. Kontoyiannis DP, Wessel VC, Bodey GP, and Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin. Infect. Dis 2000; 30: 851-856.
14. Rickerts V, Bohme A, Viertel A, Behrendt G, Jacobi V, Tintelnot K, and Just-Nubling G. Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients. Clin Infect Dis 2000; 31: 910-913.
15. Yagi S, Miyashita N, Fukuda M, Obase Y, Yoshida K, Miyauchi A, and et al. Pulmonary mucormycosis (Cunninghamella bertholletiae) with cavitation diagnosed using ultra-thin fibre-optic bronchoscopy. Respirology 2008; 13: 312-404.
16. Sharma A, Gupta V, Singh RS, Kakkar N, Singh S, and Bambery P. Angioinvasive pulmonary mucormycosis presenting as multiple bilateral pulmonary nodules in a patient without obvious predisposing factors. Singapore Med J 2008; 49: 269-271.
17. Lehrer RJ, Howard DH, Sypherd PS, Edwards JE, Segal GP, Winston DJ. Mucormycosis. Ann Intern Med 1980, 93: 93-108.